GoodRx Holdings Inc. (GDRX) 10% Owner Owns Stock Worth $2600.0


GoodRx Holdings Inc. (NASDAQ:GDRX) finished Wednesday with a subtraction of -$0.26 to close at $5.45, a downside of -4.55 percent. An average of 2,343,340 shares of common stock have been traded in the last five days. There was a fall of -$0.97 in the past week, and it reached a new high 3 times over the past 12 months. The last 20 days have seen an average of 2,514,510 shares traded, while the 50-day average volume stands at 3,789,762.

GDRX stock has decreased by -10.07% in the last month. The company shares reached their 1-month lowest point of $5.44 on 09/21/22. With the stock rallying to its 52-week high on 01/03/22, shares of the company touched a low of $5.59 and a high of $48.05 in 52 weeks. It has reached a new high 1 time so far this year and lost -83.32% or -$27.23 in price. In spite of this, the price is down -88.66% from the 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Insider Transactions

262 days have passed since GoodRx Holdings Inc. (GDRX) last reported insider trading activity. Idea Men, LLC, who is 10% Owner, most recently acquired $2,600 shares at $33.05 per share on Jan 03. In this transaction, the insider spent $85,927. President, Consumer, Slutsky Andrew, disposed of 35,829 shares at a price of $32.40 on Jan 03. The insider now owns more than $1,160,796 worth of shares. Prior to that, Chief Financial Officer Voermann Karsten went on to Sale 12,500 shares at $33.05 each on Dec 28. An amount of $413,182 was transacted.

Valuation Metrics

GoodRx Holdings Inc. (GDRX) has a trailing price-to-sales (P/S) ratio at 2.93, the price-to-book (PB) ratio at 2.75, and the price-to-cash flow ratio at 13.45.

Financial Health

The quick ratio of GoodRx Holdings Inc. for the three months ended June 29 was 11.20, and the current ratio was 11.20, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.80 and a total debt to equity ratio of 0.81 for the quarter ending June 29. Its gross profit as reported stood at $698.71 million compared to revenue of $745.42 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, GoodRx Holdings Inc.’s return on assets was -3.00%.

Earnings Surprise

For the three-month period that ended June 29, GoodRx Holdings Inc. had $653.83 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$1.42 million in the quarter, while revenues of $12.29 million were grew 2287.32%. The analyst consensus anticipated GoodRx Holdings Inc.’s latest quarter earnings to come in at $0.04 per share, but it turned out to be $0.06, a 50.00% surprise. For the quarter, EBITDA amounted to $10.13 million. Shareholders own equity worth $398.13 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at GoodRx Holdings Inc. (GDRX) price momentum. RSI 9-day as of the close on 21 September was 31.97%, suggesting the stock is Neutral, with historical volatility in this time frame at 65.48%.

As of today, GDRX’s price is $5.91 -15.11% or -$0.97 from its 5-day moving average. GDRX is currently trading -10.36% lower than its 20-day SMA and -63.69% lower than its 100-day SMA. However, the stock’s current price level is -15.77% below the SMA50 and -85.81% below the SMA200.

The stochastic %K and %D were 10.53% and 24.53%, respectively, and the average true range (ATR) was 0.38. With the 14-day stochastic at 0.69% and the average true range at 0.41, the RSI (14) stands at 36.85%. The stock has reached -0.51 on the 9-day MACD Oscillator while the 14-day reading was at -0.45.

Analyst Ratings

KeyBanc Capital Markets launched coverage on GoodRx Holdings Inc. (NASDAQ: GDRX) in its analyst report released on September 16, 2022. The firm assigned the stock a Sector weight rating. The consensus rating for GoodRx Holdings Inc. (GDRX) among analysts is Hold. According to current brokerage recommendations, 1 brokerage firm advise that investors sell GDRX, while 16 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 3 others rate it as a “buy”.

What is GDRX’s price target for the next 12 months?

Analysts predict a range of price targets between $6.00 and $13.00, with a median target of $10.00. Taking a look at these predictions, the average price target given by analysts for GoodRx Holdings Inc. (GDRX) stock is $9.75.


Please enter your comment!
Please enter your name here